Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

465 ARTÍCULOS , VIENDO DEL 46 AL 60

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background

Fulop T, Lacombe G, Cunnane S, Le Page A, Dupuis G, Frost EH, Bourgade-Navarro K, Goldeck D, Larbi A, Pawelec G.

Discov Med. 2013 Jan;15(80):23-32.

Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone

Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM, Trojanowski JQ.

JAMA Neurol. 2013 Apr;70(4):462-8. doi: 10.1001/jamaneurol.2013.1933.

Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations

Scahill RI, Ridgway GR, Bartlett JW, Barnes J, Ryan NS, Mead S, Beck J, Clarkson MJ, Crutch SJ, Schott JM, Ourselin S, Warren JD, Hardy J, Rossor MN, Fox NC.

J Alzheimers Dis. 2013;35(1):199-212. doi: 10.3233/JAD-121255.

Aluminum involvement in the progression of Alzheimer's disease

Walton JR.

J Alzheimers Dis. 2013;35(1):7-43. doi: 10.3233/JAD-121909.

A reliable way to detect endogenous murine β-amyloid

Teich AF, Patel M, Arancio O.

PLoS One. 2013;8(2):e55647. doi: 10.1371/journal.pone.0055647. Epub 2013 Feb 1.

Occupational exposure to extremely low-frequency magnetic fields and neurodegenerative disease: a meta-analysis

Vergara X, Kheifets L, Greenland S, Oksuzyan S, Cho YS, Mezei G.

J Occup Environ Med. 2013 Feb;55(2):135-46. doi: 10.1097/JOM.0b013e31827f37f8.

Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease

Porzoor A, Macreadie IG.

J Alzheimers Dis. 2013;35(2):217-25. doi: 10.3233/JAD-122035.

Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, Zommer N, Hamdane M, Bellenguez C, Dartigues JF, Hauw JJ, Letronne F, Ayral AM, Sleegers K, Schellens A, Broeck LV, Engelborghs S, De Deyn PP, Vandenberghe R, O'Donovan M, Owen M, Epelbaum J, Mercken M, Karran E, Bantscheff M, Drewes G, Joberty G, Campion D, Octave JN, Berr C, Lathrop M, Callaerts P, Mann D, Williams J, Buée L, Dewachter I, Van Broeckhoven C, Amouyel P, Moechars D, Dermaut B, Lambert JC; GERAD consortium.

Mol Psychiatry. 2013 Nov;18(11):1225-34. doi: 10.1038/mp.2013.1. Epub 2013 Feb 12.

Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease

Zlokovic BV.

JAMA Neurol. 2013 Apr;70(4):440-4. doi: 10.1001/jamaneurol.2013.2152.

From development to dysfunction: microglia and the complement cascade in CNS homeostasis

Zabel MK, Kirsch WM.

Ageing Res Rev. 2013 Jun;12(3):749-56. doi: 10.1016/j.arr.2013.02.001. Epub 2013 Feb 16.

Variant Alzheimer's disease with spastic paraparesis and supranuclear gaze palsy

Sinha N, Grimes D, Tokuhiro S, Sato C, Rogaeva E, Woulfe J.

Can J Neurol Sci. 2013 Mar;40(2):249-51. doi: 10.1017/s0317167100013822.

Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation

Niranjan R.

Mol Neurobiol. 2013 Dec;48(3):412-28. doi: 10.1007/s12035-013-8428-4. Epub 2013 Feb 19.

The hidden diet

Salcido RS.

Adv Skin Wound Care. 2013 Mar;26(3):102. doi: 10.1097/01.ASW.0000427928.35300.38.

The role of mitochondrial DNA mutations and free radicals in disease and ageing

Lagouge M, Larsson NG.

J Intern Med. 2013 Jun;273(6):529-43. doi: 10.1111/joim.12055. Epub 2013 Mar 7.

Key role of mitochondria in Alzheimer's disease synaptic dysfunction

Cavallucci V, Ferraina C, D'Amelio M.

Curr Pharm Des. 2013;19(36):6440-50. doi: 10.2174/1381612811319360005.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias